Increased expression of T‐plastin gene in cisplatin‐resistant human cancer cells: identification by mRNA differential display
暂无分享,去创建一个
[1] K. Kohno,et al. A human canalicular multispecific organic anion transporter (cMOAT) gene is overexpressed in cisplatin-resistant human cancer cell lines with decreased drug accumulation. , 1996, Cancer research.
[2] M. Condorelli,et al. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion , 1996, Nature Medicine.
[3] J. Yodoi,et al. Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. , 1995, Cancer research.
[4] K. Kohno,et al. Markedly Decreased Expression of Glutathione S-Transferase π Gene in Human Cancer Cell Lines Resistant to Buthionine Sulfoximine, an Inhibitor of Cellular Glutathione Synthesis (*) , 1995, The Journal of Biological Chemistry.
[5] M. Arpin,et al. Functional differences between L- and T-plastin isoforms , 1994, The Journal of cell biology.
[6] G. M. Wilson,et al. Pharmacological characterization of multidrug resistant MRP-transfected human tumor cells. , 1994, Cancer research.
[7] J. Mills,et al. The cytoskeleton and membrane transport. , 1994, Current opinion in nephrology and hypertension.
[8] K. Kohno,et al. Increased expression of DNA topoisomerase I gene and collateral sensitivity to camptothecin in human cisplatin-resistant bladder cancer cells. , 1994, Cancer research.
[9] W. Dalton,et al. Expression of cytokeratin confers multiple drug resistance. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[10] P. Matsudaira,et al. Identification of I-plastin, a human fimbrin isoform expressed in intestine and kidney , 1994, Molecular and cellular biology.
[11] M. Mutoh,et al. Active Efflux System for Cisplatin in Cisplatin‐resistant Human KB Cells , 1994, Japanese journal of cancer research : Gann.
[12] G. Chu,et al. Cellular responses to cisplatin. The roles of DNA-binding proteins and DNA repair. , 1994, The Journal of biological chemistry.
[13] K. Kohno,et al. Reduction of drug accumulation in cisplatin-resistant variants of human prostatic cancer PC-3 cell line. , 1993, The Journal of urology.
[14] T. Ishikawa,et al. Glutathione-associated cis-diamminedichloroplatinum(II) metabolism and ATP-dependent efflux from leukemia cells. Molecular characterization of glutathione-platinum complex and its biological significance. , 1993, The Journal of biological chemistry.
[15] S. Howell,et al. In vitro modulation of cisplatin accumulation in human ovarian carcinoma cells by pharmacologic alteration of microtubules. , 1993, The Journal of clinical investigation.
[16] C. Lin,et al. Human plastin genes. Comparative gene structure, chromosome location, and differential expression in normal and neoplastic cells. , 1993, Journal of Biological Chemistry.
[17] K. Keyomarsi,et al. Differential display and cloning of messenger RNAs from human breast cancer versus mammary epithelial cells. , 1992, Cancer research.
[18] A. Duncan,et al. Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. , 1992, Science.
[19] J. Matthews,et al. Microfilament-dependent activation of Na+/K+/2Cl- cotransport by cAMP in intestinal epithelial monolayers. , 1992, The Journal of clinical investigation.
[20] A. Pardee,et al. Differential display of eukaryotic messenger RNA by means of the polymerase chain reaction. , 1992, Science.
[21] M. Shapero,et al. Generation of region– and species–specific expressed gene probes from somatic cell hybrids , 1992, Nature Genetics.
[22] N. Saijo,et al. Metallothionein content correlates with the sensitivity of human small cell lung cancer cell lines to cisplatin. , 1991, Cancer research.
[23] M. Cohen,et al. Complexing of actin and other nuclear proteins to DNA by cis-diamminedichloroplatinum(II) and chromium compounds. , 1991, Carcinogenesis.
[24] R. Aebersold,et al. Correction of the N-terminal sequences of the human plastin isoforms by using anchored polymerase chain reaction: identification of a potential calcium-binding domain , 1990, Molecular and cellular biology.
[25] A. M. van der Bliek,et al. Multidrug resistance phenotype of human BRO melanoma cells transfected with a wild-type human mdr1 complementary DNA. , 1990, Cancer research.
[26] K. Kohno,et al. Drug resistance to cis-diamminedichloroplatinum (II) in Chinese hamster ovary cell lines transfected with glutathione S-transferase pi gene. , 1990, Biochemical and biophysical research communications.
[27] K. Kohno,et al. Increased expression of glutathione S-transferase gene in cis-diamminedichloroplatinum(II)-resistant variants of a Chinese hamster ovary cell line. , 1989, Cancer research.
[28] A. Eastman,et al. DNA repair in cells sensitive and resistant to cis-diamminedichloroplatinum(II): host cell reactivation of damaged plasmid DNA. , 1989, Biochemistry.
[29] R. Aebersold,et al. Molecular cloning and characterization of plastin, a human leukocyte protein expressed in transformed human fibroblasts. , 1988, Molecular and cellular biology.
[30] A. Fojo,et al. Increased DNA repair as a mechanism of acquired resistance to cis-diamminedichloroplatinum (II) in human ovarian cancer cell lines. , 1988, Cancer research.
[31] D. Hamer,et al. Overexpression of metallothionein confers resistance to anticancer drugs. , 1988, Science.
[32] Waygood Eb,et al. Sequence of cloned enzyme IIN-acetylglucosamine of the phosphoenolpyruvate:N-acetylglucosamine phosphotransferase system of Escherichia coli. , 1988 .
[33] A. Eastman,et al. Enhanced DNA repair as a mechanism of resistance to cis-diamminedichloroplatinum(II). , 1988, Biochemistry.
[34] K. Williams,et al. Isolation of cDNA clones coding for human tissue factor: primary structure of the protein and cDNA. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[35] I. Pastan,et al. Expression of a full-length cDNA for the human "MDR1" gene confers resistance to colchicine, doxorubicin, and vinblastine. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[36] P. Chomczyński,et al. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. , 1987, Analytical biochemistry.
[37] D. Housman,et al. Isolation and expression of a complementary DNA that confers multidrug resistance , 1986, Nature.
[38] J. Riordan,et al. Amplification of P-glycoprotein genes in multidrug-resistant mammalian cell lines , 1985, Nature.
[39] B. Jockusch,et al. Microinjection of actin-binding proteins and actin antibodies demonstrates involvement of nuclear actin in transcription of lampbrush chromosomes , 1984, Cell.
[40] P. Chambon,et al. Is actin a transcription initiation factor for RNA polymerase B? , 1984, The EMBO journal.
[41] P. Loehrer,et al. Drugs five years later. Cisplatin. , 1984, Annals of internal medicine.
[42] B. Spiegelman,et al. Fibronectin modulation of cell shape and lipogenic gene expression in 3t3-adipocytes , 1983, Cell.
[43] A. Feinberg,et al. Hypomethylation of ras oncogenes in primary human cancers. , 1983, Biochemical and biophysical research communications.
[44] H. Türler,et al. SV40 DNA injected into Xenopus oocyte nuclei is transcribed by RNA polymerase B. , 1979, Cell biology international reports.